Sugar Maple Asset Management »

Adma Biologics shares owned by Sugar Maple Asset Management

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Sugar Maple Asset Management from 13F filings

Historical chart of Sugar Maple Asset Management investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Sugar Maple Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Sugar Maple Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $130k 16k 8.37

More positions owned by Sugar Maple Asset Management

Abbvie (ABBV)
Ishares Tr TRS FLT RT BD (TFLO)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr 0-5 Yr Tips Etf (STIP)
Abbott Laboratories (ABT)
Ishares Silver Tr Ishares (SLV)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Vaneck Etf Trust Clo Etf (CLOI)
Fidelity Covington Trust Divid Etf Risi (FDRR)
Bny Mellon Etf Trust Ii Dynamic Value (BKDV)
Ishares Tr Msci Usa Min Etf (USMV)
Ishares Tr 0-5yr Invt Gr Cp (SLQD)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Specialized Funds Div App Etf (VIG)

View all positions for Sugar Maple Asset Management

Top funds holding Adma Biologics

BlackRock
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
Rubric Capital Management
Capital Research Global Investors
First Trust Advisors
Geode Capital Management
Caligan Partners
D. E. Shaw & Co
Dimensional Fund Advisors
Goldman Sachs Group
Nuveen
Duquesne Family Office
Morgan Stanley

View all funds holding Adma Biologics